Diabetes Protection and Restoration of Thymocyte Apoptosis in NOD Idd6 Congenic Strains
- Marie-Louise Bergman1,
- Nadia Duarte12,
- Susana Campino2,
- Marie Lundholm1,
- Vinicius Motta1,
- Kristina Lejon1,
- Carlos Penha-Gonçalves2 and
- Dan Holmberg12
- 1Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
- 2Instituto Gulbenkian de Ciencia, Oeiras, Portugal
- Address correspondence and reprint requests to Dan Holmberg, Umeå Center for Molecular Medicine, University of Umeå, S-901 87 Umeå, Sweden. dan.holmberg{at}ucmm.umu.se
Abstract
Type 1 diabetes in the nonobese diabetic (NOD) mouse is a multifactorial and polygenic disease. The NOD-derived genetic factors that contribute to type 1 diabetes are named Idd (insulin-dependent diabetes) loci. To date, the biological functions of the majority of the Idd loci remain unknown. We have previously reported that resistance of NOD immature thymocytes to depletion by dexamethazone (Dxm) maps to the Idd6 locus. Herein, we refine this phenotype using a time-course experiment of apoptosis induction upon Dxm treatment. We confirm that the Idd6 region controls apoptosis resistance in immature thymocytes. Moreover, we establish reciprocal Idd6 congenic NOD and B6 strains to formally demonstrate that the Idd6 congenic region mediates restoration of the apoptosis resistance phenotype. Analysis of the Idd6 congenic strains indicates that a 3-cM chromosomal region located within the distal part of the Idd6 region controls apoptosis resistance in NOD immature thymocytes. Together, these data support the hypothesis that resistance to Dxm-induced apoptosis in NOD immature thymocytes is controlled by a genetic factor within the region that also contributes to type 1 diabetes pathogenesis. We propose that the diabetogenic effect of the Idd6 locus is exerted at the level of the thymic selection process.
- APC, antigen-presenting cell
- GR, glucocorticoid receptor
- LOD, logarithm of odds
- NK, natural killer
- PI, propidium iodide
- QTL, quantitative trait locus
- TCR, T-cell receptor
- Dxm, dexamethazone
- TdT, terminal deoxynucleotidyl transferase
- Th, T helper
- TUNEL, TdT-mediated dUTP nick-end labeling
Footnotes
-
M.-L.B. and N.D. contributed equally to the work.
-
- Accepted April 10, 2003.
- Received September 19, 2002.
- DIABETES











